BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
March 28, 2003
View Archived Issues
Telik Begins Registration Study Of TLK286 In Ovarian Cancer
Plans to push its lead compound into a Phase III trial has Telik Inc. beaming like a proud parent at a child's graduation. (BioWorld Today)
Read More
Project BioShield Raises Number Of Questions Among Lawmakers
Read More
Concert Of Genes, Proteins, Stem Cells Directs Embryo's Production Of Epidermal Skin Or Hair Follicles
Read More
Cypress Bioscience Raises $10.3M For Milnacipran Phase III Program
Read More
Other News To Note
Read More